Young R C, Schumann R, Zhang P
Department of Obstetrics and Gynecology, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
J Soc Gynecol Investig. 2001 Jul-Aug;8(4):210-5. doi: 10.1016/s1071-5576(01)00109-5.
To determine whether nifedipine inhibits capacitative calcium entry at clinically relevant concentrations using cultured human myocytes as a model for human myometrium.
Myocyte cultures were initiated from the myometrium of term pregnant women who underwent cesarean delivery. Paired cells were chosen for study. The cell of interest was stimulated by an intercellular calcium wave from the adjacent cell. In this fashion, release of sarcoplasmic reticulum (SR) calcium was accomplished with minimal disturbance of the plasma membrane and the subplasmalemmal space (SPS) of the cell studied. Depletion of the SR calcium stores by the calcium wave activated the capacitative calcium current, elevated calcium in the SPS, and activated calcium-activated potassium channels. A cell-attached patch clamp was used to monitor the outward current resulting from the calcium activation of these potassium channels. Calcium green-1 fluorescence was used to simultaneously monitor changes of the deep cytosolic calcium concentrations. Experiments were performed at varying concentrations of nifedipine (0-10 micromol/L).
Nifedipine reduced outward potassium currents in a dose-dependent manner. Nifedipine at 100 nmol/L resulted in greater than a 50% reduction of outward current, indicating a significant inhibition of capacitative calcium entry at that concentration. Higher concentrations of nifedipine abolished outward current. Experiments designed to detect indirect effects of nifedipine on capacitative calcium entry were negative.
Nifedipine block of capacitative calcium entry occurred at concentrations similar to those required to block L-type voltage-activated calcium channels. These data suggest that block of capacitative calcium entry may be an important mechanism of action when nifedipine is clinically used for tocolysis of preterm labor.
以培养的人肌细胞作为人子宫肌层的模型,确定硝苯地平在临床相关浓度下是否抑制容量性钙内流。
从行剖宫产的足月孕妇子宫肌层开始进行肌细胞培养。选择成对的细胞进行研究。感兴趣的细胞由来自相邻细胞的细胞间钙波刺激。通过这种方式,在对所研究细胞的质膜和膜下空间(SPS)干扰最小的情况下实现肌浆网(SR)钙的释放。钙波使SR钙储存耗竭,激活容量性钙电流,升高SPS中的钙,并激活钙激活钾通道。使用细胞贴附式膜片钳监测这些钾通道钙激活产生的外向电流。用钙绿-1荧光同时监测胞质深部钙浓度的变化。在不同浓度的硝苯地平(0 - 10微摩尔/升)下进行实验。
硝苯地平以剂量依赖性方式降低外向钾电流。100纳摩尔/升的硝苯地平导致外向电流降低超过50%,表明该浓度下容量性钙内流受到显著抑制。更高浓度的硝苯地平使外向电流消失。旨在检测硝苯地平对容量性钙内流间接影响的实验结果为阴性。
硝苯地平对容量性钙内流的阻断发生在与阻断L型电压激活钙通道所需浓度相似的浓度下。这些数据表明,当硝苯地平临床用于早产的保胎治疗时,阻断容量性钙内流可能是其重要的作用机制。